How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

OpenAI’s GPT-5.5 achieved a 93/100 score in ZDNET’s 10-part evaluation, showing strong performance in coding, reasoning, and creative writing. The model excelled in tasks from algorithmic ...

Recursion is more than a coding trick—it’s a powerful way to simplify complex problems in Python. From elegant tree ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. The analyst who called NVIDIA in 2010 just named his top ...

Recursion is using artificial intelligence and machine learning to accelerate drug research and development. The company benefits from partnerships with major tech and healthcare leaders, reaffirming ...

Monday - Friday, 6:00 - 7:00 PM ET In a Friday interview with CNBC's Jim Cramer, Recursion Pharmaceuticals CEO Chris Gibson discussed how his company is using artificial intelligence and machine ...

Recursion claims that its artificial-intelligence-backed drug discovery platform gets smarter each time it pinpoints a new drug candidate—which is why, even with several of those candidates already in ...

Hi, using accelerate 0.19.0 and torch 1.13.1+cu117, I encounter the following issue in a single-GPU environment at around the 740th epoch of training: Below is part of the log where recursion starts ...